6SZJ
RIP2 Kinase Catalytic Domain complex with 5amino1tertbutyl3(3methoxyphenyl)1H pyrazole4carboxamide.
Summary for 6SZJ
Entry DOI | 10.2210/pdb6szj/pdb |
Related | 6sze |
Descriptor | Receptor-interacting serine/threonine-protein kinase 2, 5-amino-1-~{tert}-butyl-3-(3-methoxyphenyl)pyrazole-4-carboxamide, CALCIUM ION, ... (4 entities in total) |
Functional Keywords | fragment based drug design (fbdd), receptor interacting protein 2 kinase, ripk2, rip2k, rip2, structure based drug design (sbdd), transferase |
Biological source | Homo sapiens |
Total number of polymer chains | 2 |
Total formula weight | 71982.72 |
Authors | Convery, M.A.,Charnley, A.K.,Shewchuk, L. (deposition date: 2019-10-02, release date: 2019-12-04, Last modification date: 2024-05-15) |
Primary citation | Haffner, C.D.,Charnley, A.K.,Aquino, C.J.,Casillas, L.,Convery, M.A.,Cox, J.A.,Elban, M.A.,Goodwin, N.C.,Gough, P.J.,Haile, P.A.,Hughes, T.V.,Knapp-Reed, B.,Kreatsoulas, C.,Lakdawala, A.S.,Li, H.,Lian, Y.,Lipshutz, D.,Mehlmann, J.F.,Ouellette, M.,Romano, J.,Shewchuk, L.,Shu, A.,Votta, B.J.,Zhou, H.,Bertin, J.,Marquis, R.W. Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors. Acs Med.Chem.Lett., 10:1518-1523, 2019 Cited by PubMed: 31749904DOI: 10.1021/acsmedchemlett.9b00141 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.53 Å) |
Structure validation
Download full validation report